ENVB
USDEnveric Biosciences Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$6.100
Máximo
$6.645
Mínimo
$5.520
Volumen
0.25M
Fundamentos de la Empresa
Capitalización de Mercado
3.0M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.07M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
Enveric expects to file Investigational New Drug application for EB-003 in early 2026 Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
Move aligns with company's vision to leverage the Greater Boston biotech hub's scientific and financial ecosystem and advance EB-003 into first-in-human trial in 2026 Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or
Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
Data establish maximum tolerated dose, supporting progression of lead neuroplastogen compound EB-003 toward IND-enabling studies and First-in-Human clinical trials Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.